scispace - formally typeset
P

Petra H.M. Peeters

Researcher at Utrecht University

Publications -  720
Citations -  73551

Petra H.M. Peeters is an academic researcher from Utrecht University. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Breast cancer. The author has an hindex of 119, co-authored 720 publications receiving 63681 citations. Previous affiliations of Petra H.M. Peeters include Memorial Sloan Kettering Cancer Center & Medical Research Council.

Papers
More filters
Journal ArticleDOI

Dietary intake of acrylamide and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

TL;DR: In the EPIC cohort, an association between estimated dietary acrylamide intake and an increased risk of developing EC was observed in the middle quartiles but not in the highest quartile; however, results from other larger cohorts or consortia, and results from biomarker studies, might add to the evidence provided by this analysis, suggesting that acryamide is not an important risk factor for EC.
Journal ArticleDOI

A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk

Ruth C. Travis, +76 more
- 01 Jan 2019 - 
TL;DR: In this article, the authors examined the association between prediagnostic concentrations of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyv vitamin D [1,25 (OH)2D], and the risk of prostate cancer overall and by tumor characteristics.
Journal ArticleDOI

Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

TL;DR: The findings suggest no association between alcohol intake and endometrial cancer risk is found.
Journal ArticleDOI

Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.

TL;DR: Incomplete staging in early-stage ovarian cancer leads to gross mis-classification in grade II and III tumours and to a lesser extent in grade I tumours, which leads to undertreatment in both surgical and adjuvant therapy.